Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #7266
Reference
MSAN(2021)10
Name
Desmopressin (Octim®) 150 micrograms per actuation nasal spray (Ferring Pharmaceuticals) - update to MSAN(2020)95
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DRUG THERAPY
PHARMACEUTICAL SERVICES
SUPPLIES
Description
1. Desmopressin (Octim®) 150 micrograms per actuation nasal spray is out of stock until the third quarter of 2023.
2. Ferring Pharmaceuticals have recalled Octim® nasal sprays, as a precautionary measure due to a lower volume of solution being observed and out of specification results of desmopressin acetate and benzalkonium chloride.
3. Desmopressin (Octim®) 15 micrograms per ml injection remains available and can be prescribed as an alternative.
2. Ferring Pharmaceuticals have recalled Octim® nasal sprays, as a precautionary measure due to a lower volume of solution being observed and out of specification results of desmopressin acetate and benzalkonium chloride.
3. Desmopressin (Octim®) 15 micrograms per ml injection remains available and can be prescribed as an alternative.
Contact Name
Contact Email
Contact Address
Created
2021-03-08 00:00:00
Click to go back to homepage